Straits Times Index
3,292.69 +10.64 (+0.32%) Nikkei
38,179.28 -226.38 (-0.59%) Hang Seng
17,763.03 +16.12 (+0.09%) FTSE 100
8,144.13 -2.90 (-0.04%) Bitcoin USD
60,205.00 -4,356.16 (-6.75%) CMC Crypto 200
1,289.81 -49.26 (-3.68%)
Genmab A/S (GMAB)
After hours:
| Previous close | 28.57 |
| Open | 27.94 |
| Bid | 27.63 x 100 |
| Ask | 27.69 x 100 |
| Day's range | 27.66 - 28.40 |
| 52-week range | 26.32 - 42.72 |
| Volume | |
| Avg. volume | 558,464 |
| Market cap | 18.29B |
| Beta (5Y monthly) | 0.78 |
| PE ratio (TTM) | 30.10 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Reuters
Denmark's Genmab to acquire ProfoundBio for $1.8 billion
The acquisition will give Genmab worldwide rights to three candidates in clinical development, they said. Genmab shares were down 1.7% at 0955 GMT. Jyske bank analyst Henrik Hallengreen Laustsen said that while the acquisition is seen as slightly positive for Genmab shares, the price is difficult to assess, and added it might be "a bit high".
- Insider Monkey
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world. If you do not want to learn about the global biotech market, head straight to the 5 Biggest Biotechnology Companies in the World. In the ever-evolving landscape of biotechnology, several companies like Novo Nordisk, Regeneron, and United […]
- Insider Monkey
Genmab A/S (NASDAQ:GMAB) Q4 2023 Earnings Call Transcript
Genmab A/S (NASDAQ:GMAB) Q4 2023 Earnings Call Transcript February 14, 2024 Genmab A/S misses on earnings expectations. Reported EPS is $0.14 EPS, expectations were $0.35. Genmab A/S isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank you […]
